APOLLOHOSP - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.9
| Stock Code | APOLLOHOSP | Market Cap | 1,04,301 Cr. | Current Price | 7,252 ₹ | High / Low | 8,100 ₹ |
| Stock P/E | 71.8 | Book Value | 648 ₹ | Dividend Yield | 0.26 % | ROCE | 16.4 % |
| ROE | 15.1 % | Face Value | 5.00 ₹ | DMA 50 | 7,453 ₹ | DMA 200 | 7,318 ₹ |
| Chg in FII Hold | -0.66 % | Chg in DII Hold | 0.38 % | PAT Qtr | 392 Cr. | PAT Prev Qtr | 420 Cr. |
| RSI | 34.3 | MACD | 9.38 | Volume | 2,69,894 | Avg Vol 1Wk | 4,08,869 |
| Low price | 6,363 ₹ | High price | 8,100 ₹ | PEG Ratio | 3.03 | Debt to equity | 0.34 |
| 52w Index | 51.2 % | Qtr Profit Var | 14.8 % | EPS | 100 ₹ | Industry PE | 43.5 |
📊 Analysis: APOLLOHOSP shows strong fundamentals but is currently trading at stretched valuations. ROE at 15.1% and ROCE at 16.4% reflect decent capital efficiency. Debt-to-equity at 0.34 is moderate, indicating manageable leverage. The P/E ratio of 71.8 is significantly higher than the industry average of 43.5, suggesting overvaluation. Dividend yield at 0.26% is modest, offering limited income potential. The PEG ratio of 3.03 indicates valuations are stretched relative to growth. Technical indicators (RSI 34.3, MACD positive, price below DMA 50 & 200) show weak momentum with potential for recovery. Overall, the company is fundamentally strong but expensive, making it a cautious candidate for long-term investment.
💰 Ideal Entry Zone: ₹6,600 – ₹7,000, closer to support levels, aligning with valuation comfort and technical positioning.
📈 Exit / Holding Strategy: Existing holders should maintain a long-term horizon (3–5 years) given stable ROE/ROCE and consistent earnings. Profit booking can be considered if the price revisits ₹7,900–₹8,100. Long-term investors should monitor debt levels and quarterly profit trends for sustained growth.
Positive
- Strong ROE (15.1%) and ROCE (16.4%) highlight efficient capital allocation.
- Debt-to-equity at 0.34 indicates manageable leverage.
- EPS at ₹100 supports earnings visibility.
- DII holdings increased (+0.38%), signaling domestic institutional confidence.
Limitation
- High P/E (71.8) compared to industry average (43.5) suggests overvaluation.
- PEG ratio of 3.03 indicates stretched valuations relative to growth.
- Dividend yield (0.26%) is modest compared to peers.
- Technical indicators (RSI near 34, price below DMA 50 & 200) show weak short-term momentum.
Company Negative News
- Quarterly PAT declined (₹392 Cr vs ₹420 Cr), showing short-term weakness.
- FII holdings decreased (-0.66%), reflecting reduced foreign investor confidence.
Company Positive News
- Quarterly profit variance (+14.8%) highlights operational improvement.
- Strong 52-week performance (+51.2%) reflects investor optimism.
Industry
- Industry P/E at 43.5 is lower than company’s P/E (71.8), suggesting peers may offer better value.
- Healthcare sector growth supported by rising demand, medical tourism, and infrastructure expansion.
Conclusion
⚖️ APOLLOHOSP is fundamentally strong with decent ROE/ROCE and consistent earnings, making it a fair candidate for long-term investment. Ideal entry is around ₹6,600–₹7,000. Existing holders should maintain a 3–5 year horizon, booking profits near ₹7,900–₹8,100. While fundamentals are solid, high valuations and weak technicals warrant cautious positioning.